No Data
Express News | Fulgent Genetics Inc - Contract Value up to $99 Million Over Five Years
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
Fulgent Genetics, Inc. (NASDAQ:FLGT) Investors Are Less Pessimistic Than Expected
Those Who Invested in Fulgent Genetics (NASDAQ:FLGT) Five Years Ago Are up 107%
How Much Upside Is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22%
Silverbat : Buy at dips and hold for 192